抗体药物合物超出了细胞毒性有效载荷的范围
1Small Molecule Therapeutics & Platform Technologies, AbbVie Bioresearch Center, Worcester, MA, United States.
Progress in medicinal chemistry
|November 19, 2023
概括
抗体药物合物 (ADC) 现在提供针对性交付的多种有效载荷超出细胞毒剂的癌症治疗. 新的非细胞毒性有效载荷,包括葡萄糖皮质体受体调节器 (GRMs),扩大了ADC在瘤学和其他领域的治疗潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 抗体药物联合体 (ADC) 已经显著发展,超过十几个已被批准用于癌症治疗.
- Brentuximab vedotin建立了一个成功的ADC模板,涉及溶酶体有效载荷释放和特定的结合方法.
- 该领域正在扩大,超越细胞毒性有效载荷,包括从药物化学计划中获得的非细胞毒性化合物.
研究的目的:
- 审查新的ADC方法和新的非细胞毒性有效载荷的药物化学起源.
- 为了突出ADC有效载荷多样性的扩展到非细胞毒性类别.
- 讨论在瘤学和非瘤学治疗领域探索这些有效载荷.
主要方法:
- 审查现有的文献和ADCs的临床批准.
- 对开发新的ADC有效载荷的药物化学策略的分析.
- 检查有效载荷类,链接器技术和结合方法.
主要成果:
- ADCs已经从主要的细胞毒性有效载荷过渡到更广泛的化合物.
- 新的有效载荷类,源于小分子药物发现,为ADC开发提供了有价值的起点.
- 葡萄糖皮质体受体调节剂 (GRMs) 是一种临床上先进的非细胞毒性有效载荷类,目前正在瘤学中进行探索.
结论:
- ADC有效载荷的演变扩大了它们的治疗适用性,超出了传统的细胞毒剂.
- 药物化学的洞察力对于设计有效的非细胞毒性有效载荷和链接器至关重要.
- 新型有效载荷的跨学科应用,如GRMs,意味着有针对性的治疗领域的成熟和扩展.
关键词:
抗体药物联合体 (ADC) 是一种抗体药物联合体.可切割的链接器葡萄糖皮质体受体调节器 (GRM)希斯脱乙酶 (HDAC) 的使用免疫学ADC (iADC) 是一种免疫学ADC.免疫刺激性ADC (isADC) 是一种素螺旋蛋白 (KSP) 是一种蛋白质.尼古丁胺胺酸基转移酶 (NAMPT) 的使用不能切割的链接器这是一种类固醇.干扰素基因 (STING) 的刺激器收费类受体 (TLR) 是一种类型的受体.更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.7K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
6.9K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Cytotoxic T Cells-mediated Immune Response
924
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
924
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Antidotes
653
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
653
